Proteasome Inhibitor [EPC]

Proteasome Inhibitor [EPC] was reported 114624 times

Drugs of the Proteasome Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PLASMA CELL MYELOMA REFRACTORY 919 0.6868
1 PRIMARY AMYLOIDOSIS 139 0.5409
2 PLASMA CELL LEUKAEMIA 288 0.4800
3 PLASMA CELL MYELOMA RECURRENT 1479 0.4549
4 LEUKAEMIA PLASMACYTIC 57 0.3519
5 PLASMACYTOMA 624 0.3349
6 BLOOD STEM CELL HARVEST FAILURE 47 0.3176
7 PLASMA CELL MYELOMA 11145 0.2854
8 HYPERVISCOSITY SYNDROME 73 0.2535
9 LIGHT CHAIN ANALYSIS INCREASED 240 0.2323
10 MONOCLONAL IMMUNOGLOBULIN INCREASED 59 0.2063
11 AUTONOMIC NEUROPATHY 185 0.1826
12 IVTH NERVE PARALYSIS 42 0.1772
13 PARAPROTEINAEMIA 54 0.1742
14 PLASMABLASTIC LYMPHOMA 62 0.1732
15 MONOCLONAL IMMUNOGLOBULIN PRESENT 131 0.1724
16 RENAL AMYLOIDOSIS 41 0.1673
17 B-CELL TYPE ACUTE LEUKAEMIA 115 0.1567
18 MULTIPLE MYELOMA 681 0.1460
19 AMYLOIDOSIS 247 0.1431
20 MANTLE CELL LYMPHOMA 214 0.1405
21 CARDIAC AMYLOIDOSIS 149 0.1353
22 STEM CELL TRANSPLANT 305 0.1220
23 B PRECURSOR TYPE ACUTE LEUKAEMIA 46 0.1186
24 OSTEOLYSIS 236 0.1153
25 POLYNEUROPATHY 1190 0.0993
26 CHALAZION 62 0.0967
27 MONOCLONAL GAMMOPATHY 59 0.0941
28 PERIPHERAL SENSORIMOTOR NEUROPATHY 116 0.0923
29 MENINGITIS LISTERIA 42 0.0824
30 PERIPHERAL MOTOR NEUROPATHY 114 0.0813
31 HERPES ZOSTER DISSEMINATED 63 0.0785
32 PERIPHERAL SENSORY NEUROPATHY 457 0.0781
33 ENGRAFTMENT SYNDROME 46 0.0778
34 TUMOUR LYSIS SYNDROME 659 0.0748
35 NEUROPATHY PERIPHERAL 7016 0.0737
36 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 59 0.0726
37 BONE LESION 258 0.0715
38 FEBRILE INFECTION 83 0.0705
39 GASTROINTESTINAL TOXICITY 331 0.0688
40 PNEUMONIA INFLUENZAL 80 0.0672
41 METAPNEUMOVIRUS INFECTION 51 0.0651
42 THERAPY PARTIAL RESPONDER 1009 0.0646
43 PNEUMONIA PNEUMOCOCCAL 95 0.0641
44 PNEUMOCOCCAL SEPSIS 41 0.0624
45 ACUTE LYMPHOCYTIC LEUKAEMIA 175 0.0618
46 CYTOPENIA 755 0.0616
47 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 48 0.0609
48 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 51 0.0605
49 OCULAR TOXICITY 65 0.0589
50 NEUROPATHY 99 0.0582
51 THROMBOTIC MICROANGIOPATHY 562 0.0576
52 HYPOGAMMAGLOBULINAEMIA 378 0.0575
53 PARAINFLUENZAE VIRUS INFECTION 86 0.0565
54 KERATOPATHY 86 0.0543
55 PROTEIN TOTAL INCREASED 137 0.0514
56 DEVICE RELATED SEPSIS 102 0.0506
57 TRANSPLANT 120 0.0505
58 HAEMOLYTIC URAEMIC SYNDROME 116 0.0500
59 PATHOLOGICAL FRACTURE 253 0.0498
60 CYTOMEGALOVIRUS INFECTION REACTIVATION 217 0.0491
61 EMPYEMA 97 0.0487
62 HEMIANOPIA 46 0.0464
63 THROMBOTIC THROMBOCYTOPENIC PURPURA 163 0.0462
64 KLEBSIELLA SEPSIS 51 0.0453
65 BLOOD IMMUNOGLOBULIN G INCREASED 55 0.0452
66 ILEUS PARALYTIC 201 0.0450
67 BONE MARROW TRANSPLANT 85 0.0448
68 PULMONARY SEPSIS 65 0.0447
69 THROMBOCYTOPENIA 4996 0.0446
70 HYPERCALCAEMIA 550 0.0445
71 PSEUDOMONAL SEPSIS 78 0.0445
72 HAEMATOTOXICITY 423 0.0445
73 NEUTROPENIC INFECTION 42 0.0439
74 ESCHERICHIA SEPSIS 125 0.0431
75 JC VIRUS INFECTION 68 0.0425
76 H1N1 INFLUENZA 59 0.0420
77 STAPHYLOCOCCAL BACTERAEMIA 179 0.0411
78 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 95 0.0405
79 SPINAL CORD COMPRESSION 156 0.0400
80 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 56 0.0399
81 DEMYELINATING POLYNEUROPATHY 41 0.0398
82 HEPATITIS B REACTIVATION 122 0.0384
83 ESCHERICHIA BACTERAEMIA 90 0.0382
84 PNEUMONIA CYTOMEGALOVIRAL 74 0.0381
85 STREPTOCOCCAL BACTERAEMIA 41 0.0377
86 PNEUMOCYSTIS JIROVECII INFECTION 45 0.0377
87 ENTEROCOCCAL INFECTION 175 0.0362
88 DIVERTICULAR PERFORATION 74 0.0359
89 BACTERIAL SEPSIS 116 0.0356
90 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 327 0.0342
91 RHINOVIRUS INFECTION 132 0.0339
92 SECONDARY IMMUNODEFICIENCY 41 0.0337
93 LYMPHOPENIA 470 0.0332
94 ORTHOSTATIC HYPOTENSION 573 0.0329
95 MYELODYSPLASTIC SYNDROME 475 0.0328
96 EXPOSED BONE IN JAW 71 0.0327
97 HEPATITIS E 51 0.0323
98 NEUROGENIC BLADDER 68 0.0322
99 IMMUNOGLOBULINS DECREASED 44 0.0320
100 HORDEOLUM 137 0.0316
101 PANCYTOPENIA 1754 0.0314
102 GUILLAIN-BARRE SYNDROME 150 0.0310
103 COMPRESSION FRACTURE 166 0.0309
104 PNEUMONIA FUNGAL 122 0.0309
105 LOBAR PNEUMONIA 57 0.0308
106 SOFT TISSUE INFECTION 56 0.0306
107 FEBRILE BONE MARROW APLASIA 129 0.0303
108 ADENOCARCINOMA OF COLON 56 0.0299
109 INTERCEPTED PRODUCT PREPARATION ERROR 367 0.0298
110 INTERVERTEBRAL DISCITIS 56 0.0297
111 NEOPLASM SKIN 46 0.0296
112 HYPOPHOSPHATAEMIA 217 0.0293
113 BRAIN NATRIURETIC PEPTIDE INCREASED 89 0.0288
114 BACTERAEMIA 339 0.0285
115 COVID-19 PNEUMONIA 337 0.0285
116 ACUTE PULMONARY OEDEMA 156 0.0278
117 EMBOLISM VENOUS 84 0.0277
118 SQUAMOUS CELL CARCINOMA OF SKIN 167 0.0276
119 APLASIA 54 0.0276
120 KLEBSIELLA INFECTION 138 0.0273
121 CYTOMEGALOVIRUS VIRAEMIA 121 0.0272
122 NEUTROPENIC SEPSIS 192 0.0269
123 CARDIOTOXICITY 238 0.0267
124 SPINAL COMPRESSION FRACTURE 220 0.0266
125 NEUTROPENIA 3609 0.0265
126 IGA NEPHROPATHY 44 0.0265
127 FEBRILE NEUTROPENIA 1755 0.0264
128 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 217 0.0263
129 ADENOVIRUS INFECTION 76 0.0262
130 HEPATITIS B 157 0.0260
131 CYSTITIS HAEMORRHAGIC 105 0.0260
132 BRONCHOPULMONARY ASPERGILLOSIS 201 0.0259
133 TROPONIN I INCREASED 43 0.0258
134 PLATELET COUNT DECREASED 2736 0.0256
135 SEPTIC SHOCK 1115 0.0256
136 CYTOMEGALOVIRUS INFECTION 425 0.0255
137 PNEUMONIA KLEBSIELLA 47 0.0255
138 CLOSTRIDIUM DIFFICILE COLITIS 271 0.0255
139 BK VIRUS INFECTION 86 0.0255
140 ATRIAL FLUTTER 203 0.0254
141 BLEPHARITIS 102 0.0254
142 ESSENTIAL HYPERTENSION 46 0.0251
143 CHRONIC GRAFT VERSUS HOST DISEASE 90 0.0249
144 DISEASE PROGRESSION 2945 0.0249
145 NEUROTOXICITY 430 0.0245
146 FULL BLOOD COUNT DECREASED 490 0.0243
147 VARICELLA ZOSTER VIRUS INFECTION 50 0.0241
148 CYTOMEGALOVIRUS CHORIORETINITIS 47 0.0241
149 BONE MARROW FAILURE 488 0.0240
150 PERIODONTITIS 52 0.0240
151 DIASTOLIC DYSFUNCTION 74 0.0239
152 AUTONOMIC NERVOUS SYSTEM IMBALANCE 70 0.0239
153 ACUTE MYELOID LEUKAEMIA 370 0.0237
154 PNEUMONIA VIRAL 75 0.0235
155 MENINGITIS CRYPTOCOCCAL 41 0.0234
156 STAPHYLOCOCCAL SEPSIS 115 0.0233
157 CAPILLARY LEAK SYNDROME 48 0.0232
158 NEUTROPENIC COLITIS 48 0.0232
159 KYPHOSIS 41 0.0232
160 BLOOD CULTURE POSITIVE 69 0.0230
161 CARDIAC FAILURE ACUTE 153 0.0229
162 LEFT VENTRICULAR FAILURE 79 0.0229
163 DISTURBANCE IN SOCIAL BEHAVIOUR 54 0.0229
164 ABDOMINAL ABSCESS 101 0.0228
165 BONE MARROW DISORDER 69 0.0228
166 LUNG INFILTRATION 197 0.0223
167 PNEUMONIA STAPHYLOCOCCAL 44 0.0223
168 HYPOALBUMINAEMIA 173 0.0222
169 SECOND PRIMARY MALIGNANCY 184 0.0221
170 NOCARDIOSIS 56 0.0219
171 ACUTE GRAFT VERSUS HOST DISEASE 100 0.0218
172 INTENTIONAL PRODUCT USE ISSUE 1846 0.0211
173 PNEUMONIA BACTERIAL 192 0.0209
174 NON-CARDIAC CHEST PAIN 66 0.0208
175 NEUTROPHIL COUNT DECREASED 849 0.0208
176 FAILURE TO THRIVE 108 0.0208
177 MYELOSUPPRESSION 748 0.0207
178 ILEUS 255 0.0205
179 HYPOCALCAEMIA 387 0.0204
180 VENOUS THROMBOSIS LIMB 42 0.0203
181 SEPSIS 2261 0.0203
182 EMBOLISM 168 0.0202
183 DERMATITIS EXFOLIATIVE GENERALISED 70 0.0201
184 RESPIRATORY TRACT INFECTION 523 0.0201
185 LEFT VENTRICULAR DYSFUNCTION 134 0.0200
186 CYTOKINE RELEASE SYNDROME 400 0.0199
187 MUCOSAL INFLAMMATION 519 0.0198
188 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 46 0.0198
189 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 42 0.0197
190 VARICELLA 47 0.0197
191 PNEUMOCYSTIS JIROVECII PNEUMONIA 197 0.0196
192 CARDIAC DYSFUNCTION 73 0.0196
193 GRAFT VERSUS HOST DISEASE 140 0.0194
194 OSTEONECROSIS OF JAW 481 0.0194
195 BRAIN ABSCESS 49 0.0193
196 PROTEIN TOTAL DECREASED 72 0.0191
197 ATELECTASIS 183 0.0189
198 VENTRICULAR DYSFUNCTION 49 0.0189
199 PSEUDOMEMBRANOUS COLITIS 42 0.0188
200 ANAEMIA MACROCYTIC 40 0.0187
201 PULMONARY ALVEOLAR HAEMORRHAGE 105 0.0187
202 CARDIAC FAILURE 1498 0.0186
203 ANAEMIA 3553 0.0186
204 ERYSIPELAS 93 0.0185
205 HYPERURICAEMIA 76 0.0185
206 PLEURITIC PAIN 51 0.0185
207 LUNG INFECTION 284 0.0183
208 DEEP VEIN THROMBOSIS 1187 0.0182
209 THROMBOPHLEBITIS 64 0.0182
210 LEUKOPENIA 913 0.0182
211 OSTEITIS 46 0.0182
212 URINARY TRACT INFECTION BACTERIAL 46 0.0182
213 LARGE INTESTINE PERFORATION 126 0.0181
214 EJECTION FRACTION DECREASED 280 0.0180
215 PERFORMANCE STATUS DECREASED 84 0.0180
216 CANCER PAIN 46 0.0180
217 LUNG CONSOLIDATION 50 0.0179
218 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 455 0.0177
219 HICCUPS 145 0.0176
220 LABORATORY TEST ABNORMAL 520 0.0176
221 UROSEPSIS 162 0.0175
222 ASPERGILLUS INFECTION 114 0.0174
223 ACUTE RESPIRATORY DISTRESS SYNDROME 307 0.0173
224 BASAL CELL CARCINOMA 270 0.0173
225 VENOOCCLUSIVE LIVER DISEASE 85 0.0172
226 HERPES ZOSTER 985 0.0171
227 SYSTEMIC CANDIDA 43 0.0171
228 LEFT VENTRICULAR HYPERTROPHY 73 0.0170
229 THERAPY NON-RESPONDER 766 0.0170
230 ACTINIC KERATOSIS 44 0.0169
231 BLOOD IMMUNOGLOBULIN G DECREASED 42 0.0169
232 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 174 0.0169
233 THORACIC VERTEBRAL FRACTURE 50 0.0169
234 CLOSTRIDIAL INFECTION 57 0.0168
235 VENOUS THROMBOSIS 66 0.0168
236 ATYPICAL PNEUMONIA 50 0.0167
237 CARDIOMYOPATHY 247 0.0167
238 MULTIPLE ORGAN DYSFUNCTION SYNDROME 464 0.0164
239 PNEUMONIA 5273 0.0163
240 ENTEROCOLITIS 94 0.0163
241 ELECTROLYTE IMBALANCE 188 0.0162
242 SUDDEN DEATH 171 0.0161
243 WHITE BLOOD CELL COUNT DECREASED 1741 0.0160
244 BRONCHOPNEUMONIA 55 0.0160
245 ESCHERICHIA URINARY TRACT INFECTION 68 0.0160
246 METABOLIC ENCEPHALOPATHY 48 0.0160
247 HYPERVOLAEMIA 79 0.0160
248 TOXIC SKIN ERUPTION 161 0.0160
249 HUMERUS FRACTURE 77 0.0160
250 INFUSION RELATED REACTION 1053 0.0159
251 BLOOD LACTATE DEHYDROGENASE INCREASED 249 0.0157
252 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 60 0.0157
253 BRONCHIOLITIS 55 0.0156
254 PSEUDOMONAS INFECTION 134 0.0156
255 SQUAMOUS CELL CARCINOMA 147 0.0156
256 CONGESTIVE CARDIOMYOPATHY 65 0.0156
257 LEUKOENCEPHALOPATHY 58 0.0156
258 TRANSPLANT REJECTION 124 0.0155
259 ACUTE RESPIRATORY FAILURE 294 0.0153
260 INFECTION 2202 0.0152
261 RASH MACULO-PAPULAR 337 0.0151
262 ESCHERICHIA INFECTION 124 0.0151
263 HAEMOLYTIC ANAEMIA 135 0.0151
264 ATRIAL FIBRILLATION 1459 0.0150
265 BONE DISORDER 273 0.0150
266 PULMONARY HYPERTENSION 312 0.0150
267 RESPIRATORY SYNCYTIAL VIRUS INFECTION 130 0.0149
268 TROPONIN INCREASED 113 0.0148
269 TRICUSPID VALVE INCOMPETENCE 118 0.0148
270 HAEMOLYSIS 114 0.0147
271 SUDDEN CARDIAC DEATH 50 0.0146
272 CLOSTRIDIUM DIFFICILE INFECTION 313 0.0143
273 UPPER RESPIRATORY TRACT INFECTION 661 0.0143
274 HYPOKALAEMIA 657 0.0142
275 PLEURAL EFFUSION 860 0.0141
276 ACUTE CORONARY SYNDROME 117 0.0141
277 VASCULAR DEVICE INFECTION 64 0.0141
278 GINGIVITIS 76 0.0141
279 PULMONARY HAEMORRHAGE 109 0.0139
280 PNEUMONITIS 377 0.0138
281 RESPIRATORY FAILURE 1009 0.0138
282 BLOOD DISORDER 110 0.0137
283 DEVICE RELATED INFECTION 211 0.0137
284 VENTRICULAR HYPOKINESIA 44 0.0137
285 INTERCEPTED PRODUCT ADMINISTRATION ERROR 105 0.0137
286 BLOOD CALCIUM INCREASED 120 0.0137
287 GENERALISED OEDEMA 169 0.0136
288 LUNG ADENOCARCINOMA 41 0.0136
289 HYPOXIA 475 0.0135
290 MITRAL VALVE INCOMPETENCE 152 0.0134
291 ORGANISING PNEUMONIA 66 0.0133
292 PULMONARY TOXICITY 94 0.0133
293 PHLEBITIS 68 0.0133
294 LUMBAR VERTEBRAL FRACTURE 60 0.0131
295 CANDIDA INFECTION 221 0.0131
296 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 77 0.0130
297 UNEVALUABLE EVENT 977 0.0129
298 OLIGURIA 80 0.0129
299 CARDIOMEGALY 158 0.0128
300 IMMUNOSUPPRESSION 113 0.0128
301 DEAFNESS NEUROSENSORY 42 0.0128
302 NEURALGIA 310 0.0127
303 LOOSE TOOTH 41 0.0127
304 SKIN NECROSIS 66 0.0127
305 PULMONARY OEDEMA 567 0.0126
306 SUPRAVENTRICULAR TACHYCARDIA 121 0.0126
307 ACUTE KIDNEY INJURY 1934 0.0126
308 SPINAL OSTEOARTHRITIS 111 0.0126
309 NO THERAPEUTIC RESPONSE 154 0.0126
310 MUSCULOSKELETAL CHEST PAIN 192 0.0124
311 GASTROINTESTINAL INFLAMMATION 97 0.0124
312 HAEMOGLOBIN DECREASED 1265 0.0123
313 GASTROINTESTINAL INFECTION 110 0.0123
314 NEOPLASM 141 0.0123
315 MULTI-ORGAN FAILURE 212 0.0123
316 NEPHROTIC SYNDROME 84 0.0122
317 CACHEXIA 63 0.0122
318 MYOPATHY 105 0.0121
319 RED BLOOD CELL COUNT DECREASED 346 0.0121
320 PULMONARY EMBOLISM 1131 0.0119
321 BACTERIAL INFECTION 222 0.0119
322 RENAL FAILURE 1580 0.0119
323 HYPERGLYCAEMIA 432 0.0118
324 BLOOD CREATININE INCREASED 768 0.0118
325 VENTRICULAR ARRHYTHMIA 43 0.0117
326 BLOOD CALCIUM DECREASED 131 0.0116
327 FLUID OVERLOAD 169 0.0116
328 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 87 0.0116
329 COLITIS 438 0.0115
330 RIB FRACTURE 237 0.0115
331 ENDOCARDITIS 59 0.0115
332 BLOOD PHOSPHORUS DECREASED 42 0.0115
333 AORTIC STENOSIS 40 0.0115
334 CEREBRAL ISCHAEMIA 59 0.0115
335 CONSTIPATION 2499 0.0114
336 MALNUTRITION 128 0.0114
337 RENAL FAILURE ACUTE 485 0.0114
338 SINUS TACHYCARDIA 162 0.0114
339 SMALL INTESTINAL OBSTRUCTION 140 0.0114
340 GENERAL PHYSICAL CONDITION ABNORMAL 77 0.0113
341 PYREXIA 3912 0.0113
342 AORTIC VALVE INCOMPETENCE 48 0.0113
343 AZOTAEMIA 45 0.0113
344 HERPES SIMPLEX 73 0.0112
345 CLAVICLE FRACTURE 43 0.0112
346 DISSEMINATED INTRAVASCULAR COAGULATION 158 0.0112
347 RENAL TUBULAR NECROSIS 110 0.0112
348 ENCEPHALITIS 77 0.0111
349 AMYLASE INCREASED 41 0.0111
350 HEPATOTOXICITY 247 0.0111
351 MENINGITIS 74 0.0111
352 DECUBITUS ULCER 90 0.0110
353 OESOPHAGEAL CANDIDIASIS 44 0.0110
354 ABSCESS LIMB 47 0.0110
355 DEHYDRATION 1461 0.0109
356 VIRAL UPPER RESPIRATORY TRACT INFECTION 52 0.0109
357 ENTERITIS 70 0.0109
358 BONE PAIN 637 0.0109
359 NEUROLOGICAL SYMPTOM 62 0.0108
360 RESPIRATORY DISTRESS 298 0.0108
361 CELLULITIS 544 0.0108
362 CARDIAC FAILURE CHRONIC 46 0.0108
363 HYPOVOLAEMIA 63 0.0108
364 PLATELET COUNT ABNORMAL 65 0.0107
365 APLASTIC ANAEMIA 56 0.0107
366 MYOCARDIAL ISCHAEMIA 122 0.0107
367 COLITIS ISCHAEMIC 72 0.0107
368 INFUSION SITE EXTRAVASATION 66 0.0106
369 HYPONATRAEMIA 595 0.0106
370 THROMBOSIS 849 0.0105
371 SKIN TOXICITY 59 0.0104
372 ENCEPHALOPATHY 256 0.0104
373 PERONEAL NERVE PALSY 59 0.0104
374 HYPERTHERMIA 79 0.0103
375 CARDIAC FAILURE CONGESTIVE 831 0.0103
376 AGEUSIA 258 0.0103
377 BREATH SOUNDS ABNORMAL 51 0.0103
378 FEMORAL NECK FRACTURE 53 0.0103
379 DRUG RESISTANCE 265 0.0103
380 RENAL FAILURE CHRONIC 79 0.0103
381 OSTEOMYELITIS 186 0.0103
382 RENAL IMPAIRMENT 860 0.0102
383 ANURIA 88 0.0102
384 PAPILLOEDEMA 46 0.0102
385 HYPERPYREXIA 43 0.0101
386 PYELONEPHRITIS 88 0.0101
387 RIGHT VENTRICULAR FAILURE 71 0.0101
388 PULMONARY FIBROSIS 194 0.0101
389 RECURRENT CANCER 41 0.0100
390 BUNDLE BRANCH BLOCK RIGHT 46 0.0100
391 HAEMATOCRIT DECREASED 198 0.0100
392 SPINAL FRACTURE 200 0.0100
393 BLOOD POTASSIUM DECREASED 300 0.0100
394 CARDIOGENIC SHOCK 143 0.0100
395 NEPHROPATHY 93 0.0100
396 MYOCARDITIS 114 0.0099
397 DRUG ERUPTION 176 0.0099
398 CHOLECYSTITIS ACUTE 56 0.0099
399 TASTE DISORDER 200 0.0098
400 OEDEMA PERIPHERAL 1200 0.0098
401 HYPOMAGNESAEMIA 137 0.0098
402 INTERVERTEBRAL DISC DISORDER 42 0.0098
403 NEPHROPATHY TOXIC 110 0.0098
404 OFF LABEL USE 8563 0.0098
405 DIVERTICULITIS 270 0.0097
406 NEPHROGENIC ANAEMIA 45 0.0097
407 LUNG DISORDER 476 0.0097
408 BLOOD ALBUMIN DECREASED 77 0.0097
409 LYMPHOCYTE COUNT DECREASED 171 0.0097
410 MENTAL STATUS CHANGES 268 0.0096
411 HYPERTRANSAMINASAEMIA 67 0.0096
412 HYPERTENSIVE CRISIS 107 0.0096
413 DIARRHOEA 6185 0.0096
414 TOOTH DISORDER 213 0.0096
415 SPINAL COLUMN STENOSIS 45 0.0095
416 PROTEINURIA 180 0.0095
417 DIALYSIS 134 0.0094
418 DISEASE COMPLICATION 43 0.0094
419 SYNCOPE 939 0.0094
420 INTESTINAL ISCHAEMIA 51 0.0093
421 PERIORBITAL OEDEMA 48 0.0092
422 BLOOD URIC ACID INCREASED 53 0.0092
423 OCCUPATIONAL EXPOSURE TO PRODUCT 59 0.0092
424 KIDNEY TRANSPLANT REJECTION 44 0.0092
425 DRUG TOLERANCE 46 0.0091
426 ACUTE MYOCARDIAL INFARCTION 268 0.0091
427 ISCHAEMIC STROKE 162 0.0091
428 GASTROENTERITIS 132 0.0090
429 PURPURA 80 0.0090
430 REFUSAL OF TREATMENT BY PATIENT 59 0.0090
431 INTERSTITIAL LUNG DISEASE 437 0.0090
432 HAEMOGLOBIN ABNORMAL 58 0.0090
433 EOSINOPHILIA 157 0.0090
434 HAEMODIALYSIS 75 0.0089
435 INTESTINAL PERFORATION 100 0.0089
436 SINUS BRADYCARDIA 86 0.0089
437 OEDEMA 482 0.0089
438 ORAL DISORDER 65 0.0089
439 BLOOD MAGNESIUM DECREASED 76 0.0088
440 HAEMORRHOIDAL HAEMORRHAGE 43 0.0088
441 FLANK PAIN 82 0.0087
442 DIVERTICULUM 62 0.0087
443 PERICARDIAL EFFUSION 200 0.0086
444 EPSTEIN-BARR VIRUS INFECTION 54 0.0086
445 STRESS CARDIOMYOPATHY 50 0.0086
446 HYPOTENSION 1720 0.0086
447 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 289 0.0085
448 STAPHYLOCOCCAL INFECTION 282 0.0085
449 BLOOD UREA INCREASED 142 0.0085
450 ECCHYMOSIS 58 0.0085
451 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 65 0.0084
452 ARRHYTHMIA 395 0.0083
453 OESOPHAGITIS 91 0.0083
454 MALIGNANT NEOPLASM PROGRESSION 851 0.0083
455 PULMONARY THROMBOSIS 90 0.0082
456 LOWER RESPIRATORY TRACT INFECTION 375 0.0082
457 SPINAL PAIN 96 0.0082
458 RENAL DISORDER 378 0.0081
459 COVID-19 1420 0.0081
460 TOXICITY TO VARIOUS AGENTS 1364 0.0081
461 NECROSIS 45 0.0081
462 BLOOD SODIUM DECREASED 152 0.0081
463 ORAL CANDIDIASIS 106 0.0080
464 HYPERNATRAEMIA 40 0.0080
465 PROTHROMBIN TIME PROLONGED 48 0.0080
466 AGRANULOCYTOSIS 149 0.0080
467 HYPERAMMONAEMIA 40 0.0080
468 INTERVERTEBRAL DISC DEGENERATION 74 0.0080
469 HYPERKALAEMIA 280 0.0080
470 ACIDOSIS 61 0.0080
471 BLOOD COUNT ABNORMAL 121 0.0080
472 PULMONARY CONGESTION 105 0.0080
473 SPLENOMEGALY 93 0.0079
474 ATRIOVENTRICULAR BLOCK COMPLETE 53 0.0079
475 C-REACTIVE PROTEIN INCREASED 288 0.0079
476 MALIGNANT MELANOMA 106 0.0079
477 HEPATIC CYTOLYSIS 100 0.0078
478 CHOLECYSTITIS 93 0.0078
479 RASH PRURITIC 420 0.0077
480 HAEMODYNAMIC INSTABILITY 59 0.0077
481 DRUG INTOLERANCE 745 0.0077
482 ARTERIOSCLEROSIS CORONARY ARTERY 51 0.0077
483 GENERAL PHYSICAL HEALTH DETERIORATION 889 0.0077
484 VASCULITIS 89 0.0076
485 HERPES VIRUS INFECTION 44 0.0076
486 ASTHENIA 2865 0.0076
487 FATIGUE 5924 0.0076
488 DECREASED APPETITE 1758 0.0076
489 SHOCK 174 0.0076
490 RENAL CYST 60 0.0075
491 URINE OUTPUT DECREASED 66 0.0075
492 STREPTOCOCCAL INFECTION 42 0.0075
493 ANOREXIA 97 0.0075
494 MULTIPLE ALLERGIES 59 0.0075
495 HYPERTRIGLYCERIDAEMIA 44 0.0075
496 APPENDICITIS 70 0.0075
497 SEASONAL ALLERGY 106 0.0075
498 BODY HEIGHT DECREASED 80 0.0075
499 PETECHIAE 78 0.0075
500 SUBDURAL HAEMATOMA 107 0.0075
501 HYPOPHAGIA 191 0.0075
502 PULMONARY ARTERIAL HYPERTENSION 108 0.0074
503 BRAIN OEDEMA 94 0.0074
504 TACHYPNOEA 101 0.0074
505 PLEURISY 44 0.0074
506 VIRAL INFECTION 244 0.0073
507 ANGIOPATHY 41 0.0073
508 TOOTH ABSCESS 74 0.0073
509 ATRIOVENTRICULAR BLOCK 56 0.0072
510 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 395 0.0072
511 ASPARTATE AMINOTRANSFERASE INCREASED 382 0.0072
512 SPINAL DISORDER 68 0.0072
513 BLOOD BILIRUBIN INCREASED 192 0.0071
514 BRONCHITIS 526 0.0071
515 TRANSAMINASES INCREASED 158 0.0071
516 LEUKAEMIA 67 0.0071
517 EYE INFECTION 80 0.0071
518 INFLUENZA 790 0.0071
519 ELECTROCARDIOGRAM QT PROLONGED 254 0.0071
520 HEPATOCELLULAR INJURY 100 0.0070
521 HEPATOMEGALY 69 0.0070
522 HEPATIC FUNCTION ABNORMAL 260 0.0070
523 COAGULOPATHY 116 0.0070
524 MASS 97 0.0069
525 VENTRICULAR EXTRASYSTOLES 72 0.0069
526 ANGINA UNSTABLE 45 0.0069
527 IMMUNODEFICIENCY 103 0.0069
528 LEUKOCYTOSIS 125 0.0069
529 DYSPNOEA EXERTIONAL 260 0.0069
530 BLOOD ALKALINE PHOSPHATASE INCREASED 171 0.0069
531 OSTEONECROSIS 226 0.0069
532 DIFFUSE LARGE B-CELL LYMPHOMA 53 0.0069
533 DELIRIUM 237 0.0068
534 ALANINE AMINOTRANSFERASE INCREASED 418 0.0068
535 GASTROINTESTINAL DISORDER 609 0.0068
536 HYPOAESTHESIA 1016 0.0068
537 VENTRICULAR TACHYCARDIA 112 0.0068
538 SUBARACHNOID HAEMORRHAGE 69 0.0068
539 URINARY TRACT INFECTION 1155 0.0068
540 GOUT 121 0.0067
541 DIARRHOEA HAEMORRHAGIC 63 0.0067
542 THERAPEUTIC RESPONSE DECREASED 408 0.0067
543 ADVERSE DRUG REACTION 604 0.0067
544 DEATH 5717 0.0066
545 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 470 0.0066
546 RASH GENERALISED 171 0.0066
547 HEPATIC FAILURE 199 0.0066
548 CHILLS 771 0.0066
549 INGUINAL HERNIA 40 0.0066
550 DISEASE RECURRENCE 312 0.0066
551 MUSCLE ATROPHY 83 0.0065
552 NERVOUS SYSTEM DISORDER 204 0.0065
553 BLOOD POTASSIUM INCREASED 106 0.0065
554 RASH 2833 0.0065
555 ARTERIOSCLEROSIS 61 0.0065
556 IMMUNE SYSTEM DISORDER 85 0.0064
557 EMPHYSEMA 65 0.0064
558 ERYTHEMA MULTIFORME 60 0.0064
559 CATARACT 383 0.0064
560 TOOTH EXTRACTION 80 0.0064
561 ADRENAL INSUFFICIENCY 78 0.0064
562 WHITE BLOOD CELL COUNT ABNORMAL 41 0.0064
563 PAIN IN JAW 182 0.0064
564 ADVERSE EVENT 592 0.0064
565 CARDIAC DISORDER 601 0.0064
566 DENTAL CARIES 71 0.0064
567 SKIN INFECTION 72 0.0064
568 THERAPY CHANGE 63 0.0064
569 WRONG DRUG ADMINISTERED 57 0.0064
570 PAPULE 45 0.0064
571 CARDIOVASCULAR DISORDER 162 0.0064
572 PRESYNCOPE 155 0.0064
573 PNEUMONIA ASPIRATION 159 0.0064
574 BACK PAIN 1474 0.0063
575 BLOOD TEST ABNORMAL 89 0.0063
576 RHINITIS 51 0.0063
577 FLUID RETENTION 320 0.0063
578 ALTERED STATE OF CONSCIOUSNESS 136 0.0063
579 ADVERSE REACTION 83 0.0063
580 PRODUCT USE ISSUE 1176 0.0063
581 END STAGE RENAL DISEASE 114 0.0062
582 CARDIAC ARREST 514 0.0062
583 PERIPHERAL SWELLING 959 0.0062
584 FACIAL PARALYSIS 53 0.0062
585 LIVER DISORDER 275 0.0062
586 CORONAVIRUS INFECTION 41 0.0062
587 CEREBRAL INFARCTION 151 0.0062
588 HYPERBILIRUBINAEMIA 64 0.0062
589 BRONCHOSPASM 88 0.0062
590 PRODUCT USE IN UNAPPROVED INDICATION 1528 0.0062
591 PANCREATITIS ACUTE 138 0.0061
592 NERVE INJURY 68 0.0061
593 CEREBRAL HAEMORRHAGE 218 0.0061
594 TOOTH INFECTION 80 0.0061
595 CONFUSIONAL STATE 980 0.0061
596 HYPERTENSION 1278 0.0060
597 URINARY RETENTION 201 0.0060
598 HAEMORRHAGE INTRACRANIAL 90 0.0060
599 CIRCULATORY COLLAPSE 102 0.0060
600 PARAESTHESIA 940 0.0060
601 HAEMORRHOIDS 116 0.0059
602 HAEMOPTYSIS 165 0.0059
603 NEOPLASM PROGRESSION 204 0.0059
604 SKIN REACTION 82 0.0058
605 INFUSION SITE ERYTHEMA 49 0.0058
606 PHARYNGITIS 72 0.0058
607 DRUG TOXICITY 79 0.0058
608 CONJUNCTIVITIS 107 0.0058
609 SKIN ULCER 149 0.0058
610 TENDERNESS 60 0.0058
611 INFUSION SITE PAIN 74 0.0057
612 LIPASE INCREASED 44 0.0057
613 CHOLESTASIS 110 0.0057
614 MOUTH HAEMORRHAGE 42 0.0057
615 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 297 0.0057
616 SARS-COV-2 TEST POSITIVE 75 0.0057
617 DIZZINESS POSTURAL 55 0.0057
618 BODY TEMPERATURE INCREASED 115 0.0056
619 TRANSIENT ISCHAEMIC ATTACK 190 0.0056
620 PRODUCT PREPARATION ERROR 115 0.0056
621 GAMMA-GLUTAMYLTRANSFERASE INCREASED 124 0.0056
622 SENSORY LOSS 45 0.0056
623 ANGINA PECTORIS 160 0.0056
624 TUBULOINTERSTITIAL NEPHRITIS 104 0.0055
625 EPISTAXIS 415 0.0055
626 DYSPNOEA 3131 0.0055
627 COGNITIVE DISORDER 258 0.0055
628 MUSCULAR WEAKNESS 627 0.0055
629 LIVER FUNCTION TEST ABNORMAL 159 0.0055
630 DERMATITIS ALLERGIC 68 0.0054
631 VENTRICULAR FIBRILLATION 60 0.0054
632 FUNGAL INFECTION 180 0.0054
633 STOMATITIS 325 0.0054
634 TOXIC EPIDERMAL NECROLYSIS 81 0.0053
635 EYELID OEDEMA 62 0.0053
636 INCREASED TENDENCY TO BRUISE 49 0.0053
637 SKIN LESION 146 0.0053
638 HEPATITIS 136 0.0053
639 CARDIO-RESPIRATORY ARREST 222 0.0053
640 ATAXIA 63 0.0053
641 UPPER GASTROINTESTINAL HAEMORRHAGE 89 0.0053
642 GASTROINTESTINAL HAEMORRHAGE 441 0.0053
643 MUSCLE SPASMS 968 0.0053
644 NEUTROPHIL COUNT INCREASED 54 0.0053
645 PELVIC FRACTURE 41 0.0053
646 TOOTH FRACTURE 58 0.0053
647 TOOTHACHE 95 0.0052
648 PERICARDITIS 88 0.0052
649 FULL BLOOD COUNT ABNORMAL 55 0.0052
650 CORONARY ARTERY DISEASE 157 0.0052
651 RESPIRATORY DISORDER 155 0.0052
652 PERIPHERAL COLDNESS 71 0.0052
653 PERITONITIS 107 0.0052
654 TRANSFUSION 54 0.0051
655 NAUSEA 4079 0.0051
656 HYPERLIPIDAEMIA 61 0.0051
657 ASCITES 150 0.0051
658 PULMONARY MASS 76 0.0051
659 DISORIENTATION 201 0.0051
660 PRODUCTIVE COUGH 242 0.0051
661 ORAL PAIN 112 0.0050
662 WEIGHT DECREASED 1395 0.0050
663 FRACTURE 93 0.0049
664 VOMITING 2307 0.0049
665 GENERALISED TONIC-CLONIC SEIZURE 81 0.0049
666 RECTAL HAEMORRHAGE 210 0.0049
667 DYSGEUSIA 363 0.0049
668 BLOOD PRESSURE ABNORMAL 97 0.0049
669 TACHYCARDIA 433 0.0049
670 DERMATITIS 102 0.0049
671 HOSPICE CARE 48 0.0049
672 INTERVERTEBRAL DISC PROTRUSION 106 0.0048
673 METABOLIC ACIDOSIS 155 0.0048
674 NIGHT SWEATS 156 0.0048
675 ASPIRATION 53 0.0048
676 GASTRITIS 126 0.0048
677 HAEMATOMA 124 0.0048
678 ULCER 76 0.0048
679 INTESTINAL OBSTRUCTION 180 0.0048
680 HAEMATURIA 163 0.0048
681 METASTASES TO BONE 78 0.0047
682 MELAENA 103 0.0047
683 BRADYCARDIA 248 0.0047
684 HIATUS HERNIA 60 0.0046
685 LOCALISED INFECTION 112 0.0046
686 COLON CANCER 69 0.0046
687 EXOSTOSIS 42 0.0046
688 WEIGHT FLUCTUATION 48 0.0046
689 FACE OEDEMA 77 0.0046
690 LETHARGY 262 0.0045
691 CHEST PAIN 842 0.0045
692 DIPLOPIA 118 0.0045
693 PRODUCT STORAGE ERROR 396 0.0045
694 CYSTITIS 143 0.0045
695 HIP FRACTURE 144 0.0045
696 FEMUR FRACTURE 138 0.0045
697 INCONTINENCE 47 0.0044
698 PANCREATITIS 235 0.0044
699 ACUTE HEPATIC FAILURE 60 0.0044
700 TREATMENT FAILURE 363 0.0044
701 MYOCLONUS 52 0.0044
702 HEPATIC ENZYME INCREASED 297 0.0044
703 LIVER FUNCTION TEST INCREASED 93 0.0043
704 FALL 1439 0.0043
705 ABASIA 106 0.0043
706 INSOMNIA 1138 0.0043
707 OXYGEN SATURATION DECREASED 240 0.0043
708 LYMPHOMA 66 0.0043
709 ABDOMINAL DISTENSION 445 0.0043
710 ABSCESS 68 0.0043
711 HOSPITALISATION 653 0.0042
712 DEAFNESS 111 0.0042
713 VISUAL ACUITY REDUCED 141 0.0042
714 RASH ERYTHEMATOUS 202 0.0042
715 PNEUMOTHORAX 67 0.0042
716 HYPOTONIA 42 0.0042
717 EYE INFLAMMATION 40 0.0042
718 SINUS DISORDER 82 0.0041
719 NOCTURIA 50 0.0041
720 INJECTION SITE RASH 125 0.0041
721 STATUS EPILEPTICUS 46 0.0041
722 COUGH 1141 0.0041
723 MUSCULOSKELETAL PAIN 213 0.0041
724 HEPATITIS C 49 0.0041
725 SKIN DISCOLOURATION 186 0.0040
726 GINGIVAL BLEEDING 55 0.0040
727 WOUND INFECTION 44 0.0040
728 HEMIPARESIS 68 0.0040
729 INTERNATIONAL NORMALISED RATIO INCREASED 114 0.0040
730 GASTRIC HAEMORRHAGE 46 0.0040
731 ABDOMINAL PAIN 927 0.0040
732 ROTATOR CUFF SYNDROME 51 0.0040
733 BLOOD IRON DECREASED 47 0.0040
734 TREMOR 657 0.0040
735 OSTEOPENIA 60 0.0039
736 GASTRIC ULCER 75 0.0039
737 SKIN DISORDER 131 0.0039
738 EPILEPSY 120 0.0039
739 UPPER LIMB FRACTURE 78 0.0039
740 HYPOAESTHESIA ORAL 59 0.0039
741 HAEMATEMESIS 99 0.0039
742 RED BLOOD CELL SEDIMENTATION RATE INCREASED 43 0.0039
743 BURSITIS 47 0.0039
744 SINUSITIS 396 0.0039
745 LIMB DISCOMFORT 119 0.0038
746 DYSURIA 140 0.0038
747 WHITE BLOOD CELL COUNT INCREASED 145 0.0038
748 STEVENS-JOHNSON SYNDROME 84 0.0038
749 GASTROENTERITIS VIRAL 68 0.0038
750 BALANCE DISORDER 325 0.0038
751 BACK DISORDER 61 0.0037
752 SWELLING FACE 244 0.0037
753 PARAESTHESIA ORAL 54 0.0037
754 BLOOD PRESSURE DECREASED 248 0.0037
755 INFLAMMATION 192 0.0037
756 SCIATICA 59 0.0037
757 IMPAIRED HEALING 121 0.0037
758 INJECTION SITE DISCOLOURATION 46 0.0037
759 DEPRESSED LEVEL OF CONSCIOUSNESS 145 0.0037
760 NASOPHARYNGITIS 673 0.0036
761 DEMENTIA 102 0.0036
762 VISION BLURRED 500 0.0036
763 SINUS CONGESTION 49 0.0036
764 EAR PAIN 70 0.0036
765 RESPIRATORY TRACT CONGESTION 57 0.0036
766 JOINT SWELLING 430 0.0036
767 DIZZINESS 1775 0.0036
768 LIVER INJURY 87 0.0035
769 LYMPHADENOPATHY 125 0.0035
770 HAEMORRHAGE 369 0.0035
771 TINNITUS 162 0.0035
772 GLOMERULAR FILTRATION RATE DECREASED 43 0.0035
773 PAIN IN EXTREMITY 1028 0.0035
774 LACRIMATION INCREASED 105 0.0035
775 HYPERSOMNIA 99 0.0034
776 UNRESPONSIVE TO STIMULI 89 0.0034
777 INJECTION SITE REACTION 237 0.0034
778 BEDRIDDEN 45 0.0034
779 URINARY INCONTINENCE 101 0.0034
780 HYPOACUSIS 146 0.0034
781 DYSPHONIA 198 0.0034
782 HEAD INJURY 107 0.0034
783 INJECTION SITE IRRITATION 43 0.0034
784 OSTEOARTHRITIS 143 0.0034
785 PARANOIA 58 0.0034
786 RESTLESS LEGS SYNDROME 61 0.0034
787 HEPATIC STEATOSIS 62 0.0033
788 LOSS OF CONSCIOUSNESS 426 0.0033
789 GLAUCOMA 64 0.0033
790 MOUTH ULCERATION 70 0.0033
791 DRUG-INDUCED LIVER INJURY 104 0.0033
792 DRY EYE 165 0.0033
793 GALLBLADDER DISORDER 59 0.0033
794 SKIN CANCER 71 0.0033
795 DYSPHAGIA 312 0.0033
796 MYOCARDIAL INFARCTION 570 0.0033
797 GASTRIC DISORDER 112 0.0033
798 DRUG INEFFECTIVE 4259 0.0032
799 CHRONIC KIDNEY DISEASE 245 0.0032
800 DRUG EFFECT INCOMPLETE 117 0.0032
801 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 75 0.0032
802 THERAPEUTIC PRODUCT EFFECT DECREASED 144 0.0032
803 LOCAL SWELLING 56 0.0032
804 RHINORRHOEA 207 0.0032
805 POLLAKIURIA 133 0.0032
806 CONTUSION 306 0.0032
807 FEEDING DISORDER 64 0.0032
808 WOUND 88 0.0031
809 APHASIA 95 0.0031
810 INCREASED APPETITE 60 0.0031
811 MUSCULOSKELETAL DISCOMFORT 54 0.0031
812 MALAISE 1375 0.0031
813 DYSPEPSIA 308 0.0031
814 DIABETES MELLITUS 238 0.0031
815 JAUNDICE 84 0.0031
816 CHEST DISCOMFORT 318 0.0031
817 EAR INFECTION 82 0.0031
818 TREATMENT NONCOMPLIANCE 168 0.0031
819 GASTROOESOPHAGEAL REFLUX DISEASE 246 0.0031
820 CYANOSIS 48 0.0030
821 TOOTH LOSS 63 0.0030
822 ARTHROPATHY 168 0.0030
823 BRAIN FOG 47 0.0030
824 EYE SWELLING 111 0.0030
825 FLATULENCE 168 0.0030
826 INFLUENZA LIKE ILLNESS 243 0.0029
827 CEREBROVASCULAR ACCIDENT 497 0.0029
828 PRESCRIBED UNDERDOSE 58 0.0029
829 NECK PAIN 160 0.0029
830 NO ADVERSE EVENT 514 0.0028
831 HYPOGLYCAEMIA 137 0.0028
832 INJECTION SITE ERYTHEMA 346 0.0028
833 ACTIVITIES OF DAILY LIVING IMPAIRED 55 0.0028
834 RASH MACULAR 97 0.0028
835 EATING DISORDER 59 0.0028
836 ORAL HERPES 54 0.0028
837 METASTASES TO LIVER 48 0.0027
838 SWELLING 255 0.0027
839 CHOLELITHIASIS 89 0.0027
840 EYE DISORDER 89 0.0027
841 SOMNOLENCE 545 0.0027
842 DYSSTASIA 79 0.0027
843 COMA 128 0.0027
844 RASH PAPULAR 60 0.0027
845 AGITATION 196 0.0027
846 GAIT DISTURBANCE 510 0.0027
847 SKIN EXFOLIATION 224 0.0027
848 OSTEOPOROSIS 109 0.0026
849 ERECTILE DYSFUNCTION 68 0.0026
850 ARTHRITIS 208 0.0026
851 PAIN 1615 0.0026
852 ABDOMINAL DISCOMFORT 441 0.0026
853 RENAL INJURY 78 0.0026
854 OROPHARYNGEAL PAIN 241 0.0026
855 HYPERSENSITIVITY 483 0.0026
856 FOOT FRACTURE 49 0.0026
857 SLEEP DISORDER 182 0.0026
858 CONDITION AGGRAVATED 781 0.0026
859 MOOD ALTERED 69 0.0025
860 GAIT INABILITY 84 0.0025
861 PRODUCT DOSE OMISSION 163 0.0025
862 HAEMATOCHEZIA 137 0.0025
863 WHEEZING 147 0.0025
864 HEART RATE DECREASED 87 0.0025
865 ABDOMINAL PAIN UPPER 510 0.0025
866 MYALGIA 421 0.0025
867 BLOOD PRESSURE INCREASED 378 0.0025
868 PSYCHOMOTOR HYPERACTIVITY 41 0.0025
869 POOR QUALITY SLEEP 53 0.0025
870 BURNING SENSATION 172 0.0025
871 HEPATIC CIRRHOSIS 46 0.0024
872 LOWER LIMB FRACTURE 47 0.0024
873 NEOPLASM MALIGNANT 163 0.0024
874 PRURITUS 936 0.0024
875 HERNIA 47 0.0024
876 WEIGHT INCREASED 543 0.0024
877 SLEEP APNOEA SYNDROME 46 0.0024
878 FEELING ABNORMAL 572 0.0024
879 LUNG NEOPLASM MALIGNANT 98 0.0024
880 VERTIGO 145 0.0024
881 LIMB INJURY 64 0.0024
882 ERYTHEMA 482 0.0023
883 PSYCHOTIC DISORDER 69 0.0023
884 SYNOVITIS 42 0.0023
885 BLOOD GLUCOSE ABNORMAL 43 0.0023
886 MUSCULOSKELETAL DISORDER 44 0.0023
887 FEELING JITTERY 44 0.0023
888 DISTURBANCE IN ATTENTION 124 0.0023
889 ABNORMAL BEHAVIOUR 90 0.0023
890 RETCHING 48 0.0022
891 PRODUCT PRESCRIBING ISSUE 49 0.0022
892 RESPIRATORY ARREST 62 0.0022
893 MEMORY IMPAIRMENT 309 0.0022
894 NEPHROLITHIASIS 103 0.0022
895 ANAPHYLACTIC REACTION 124 0.0022
896 CONVULSION 128 0.0022
897 PALPITATIONS 256 0.0022
898 BLINDNESS 89 0.0022
899 HYPERHIDROSIS 281 0.0022
900 HEART RATE INCREASED 216 0.0022
901 DRY MOUTH 176 0.0022
902 HALLUCINATION 162 0.0021
903 AMNESIA 139 0.0021
904 ABDOMINAL PAIN LOWER 54 0.0021
905 DYSARTHRIA 80 0.0021
906 URTICARIA 355 0.0021
907 BLOOD PRESSURE SYSTOLIC INCREASED 41 0.0021
908 FEELING COLD 58 0.0021
909 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 100 0.0021
910 VISUAL IMPAIRMENT 257 0.0021
911 MOBILITY DECREASED 149 0.0021
912 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 60 0.0020
913 ARTHRALGIA 849 0.0020
914 HYPOTHYROIDISM 65 0.0020
915 JOINT INJURY 43 0.0020
916 SEIZURE 232 0.0020
917 SNEEZING 45 0.0020
918 EYE PAIN 113 0.0020
919 THERAPY INTERRUPTED 143 0.0020
920 PALLOR 54 0.0020
921 PRURITUS GENERALISED 42 0.0019
922 HEADACHE 1210 0.0019
923 DISCOMFORT 117 0.0019
924 HEART RATE IRREGULAR 43 0.0019
925 OCULAR HYPERAEMIA 90 0.0019
926 BLISTER 106 0.0019
927 MENTAL DISORDER 82 0.0019
928 RESTLESSNESS 68 0.0019
929 DRY SKIN 248 0.0019
930 LACTIC ACIDOSIS 60 0.0019
931 DRUG EFFECT DECREASED 99 0.0018
932 BLOOD PRESSURE FLUCTUATION 44 0.0018
933 DEPRESSION 416 0.0018
934 INJURY 127 0.0018
935 DRUG DOSE OMISSION 298 0.0018
936 DRUG ADMINISTRATION ERROR 55 0.0018
937 NASAL CONGESTION 105 0.0018
938 MUSCULOSKELETAL STIFFNESS 156 0.0018
939 DEPRESSED MOOD 94 0.0018
940 ROAD TRAFFIC ACCIDENT 73 0.0017
941 RHABDOMYOLYSIS 72 0.0017
942 BLOOD GLUCOSE INCREASED 325 0.0017
943 NERVOUSNESS 90 0.0017
944 ASTHMA 194 0.0017
945 ILLNESS 176 0.0017
946 DRUG INTERACTION 270 0.0017
947 TYPE 2 DIABETES MELLITUS 56 0.0017
948 ALOPECIA 325 0.0017
949 MOOD SWINGS 52 0.0016
950 BLOOD CHOLESTEROL INCREASED 76 0.0016
951 ANAPHYLACTIC SHOCK 42 0.0016
952 ANXIETY 457 0.0016
953 SPEECH DISORDER 84 0.0016
954 PROSTATE CANCER 128 0.0016
955 ANGIOEDEMA 70 0.0016
956 FEELING HOT 97 0.0016
957 INCORRECT ROUTE OF DRUG ADMINISTRATION 56 0.0016
958 PRODUCT DOSE OMISSION ISSUE 459 0.0016
959 INTENTIONAL PRODUCT MISUSE 134 0.0015
960 MEDICATION ERROR 85 0.0015
961 INJECTION SITE PRURITUS 102 0.0015
962 THROAT IRRITATION 65 0.0014
963 HOT FLUSH 109 0.0014
964 SWOLLEN TONGUE 45 0.0014
965 EYE PRURITUS 48 0.0014
966 BREAST CANCER 133 0.0014
967 THERAPEUTIC RESPONSE UNEXPECTED 60 0.0013
968 IRRITABILITY 80 0.0013
969 ILL-DEFINED DISORDER 79 0.0013
970 THERAPY CESSATION 65 0.0013
971 FLUSHING 126 0.0012
972 BLOOD GLUCOSE DECREASED 58 0.0012
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 80 0.0011
974 ECZEMA 57 0.0011
975 DYSKINESIA 44 0.0011
976 SURGERY 61 0.0010
977 EYE IRRITATION 59 0.0010
978 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 169 0.0009
979 MIGRAINE 89 0.0009
980 ACCIDENTAL EXPOSURE TO PRODUCT 94 0.0009
981 AGGRESSION 45 0.0009
982 BLADDER CANCER 49 0.0008
983 INJECTION SITE BRUISING 65 0.0008
984 EMOTIONAL DISTRESS 96 0.0008
985 INJECTION SITE SWELLING 58 0.0008
986 SKIN BURNING SENSATION 42 0.0006
987 SUICIDAL IDEATION 52 0.0006
988 INJECTION SITE PAIN 165 0.0005
989 INCORRECT DOSE ADMINISTERED 118 0.0005
990 DRUG ABUSE 40 0.0005
991 OVERDOSE 103 0.0005
992 RHEUMATOID ARTHRITIS 50 0.0004
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 72 0.0004
994 PSORIASIS 42 0.0003